Microtubule Cytoskeletal Network Alterations in a Transgenic Model of Tuberous Sclerosis Complex: Relevance to Autism Spectrum Disorders

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism

Di Martino, A., Yan, C.-G., Li, Q., Denio, E., Castellanos, F. X., Alaerts, K., Anderson, J. S., Assaf, M., Bookheimer, S. Y., Dapretto, M., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.78 · Cited by 2,780 · see citing works

Tau in physiology and pathology

Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251 · see citing works

Neuroanatomy of autism

Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · see citing works

Neurofilament light chain as a biomarker in neurological disorders

Gaetani, L., Blennow, K., Calabresi, P., Di Filippo, M., Parnetti, L., & Zetterberg, H. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-320106 · Cited by 1,334 · see citing works

The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease

Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201 · see citing works

Loss of mTOR-Dependent Macroautophagy Causes Autistic-like Synaptic Pruning Deficits

Tang, G., Gudsnuk, K., Kuo, S.-H., Cotrina, M. L., Rosoklija, G., Sosunov, A., Sonders, M. S., Kanter, E., Castagna, C., Yamamoto, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.040 · Cited by 1,146 · see citing works

Tau in Alzheimer Disease and Related Tauopathies

Iqbal, K., Liu, F., Gong, C., & Grundke, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611592 · Cited by 1,122 · see citing works

Microtubule assembly, organization and dynamics in axons and dendrites

Conde, C., & Cáceres, A. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2631 · Cited by 1,086 · see citing works

Tau pathology in Alzheimer disease and other tauopathies

Iqbal, K., del C. Alonso, A., Chen, S., Chohan, M. O., El-Akkad, E., Gong, C.-X., Khatoon, S., Li, B., Liu, F., Rahman, A., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.09.008 · Cited by 1,037 · see citing works

The MAP1 family of microtubule-associated proteins.

Dehmelt (2004) · Genome biology · doi:10.1186/gb-2004-6-1-204 · Cited by 972 · see citing works

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903 · see citing works

Phosphorylation affects the ability of tau protein to promote microtubule assembly.

Lindwall, G., & Cole, R. D. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42989-9 · Cited by 901 · see citing works

Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis

Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 879 · see citing works

Tuberous sclerosis complex

Henske, E. P., Jóźwiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.35 · Cited by 856 · see citing works

Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders

Hutsler, J. J., & Zhang, H. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.120 · Cited by 765 · see citing works

Neurofilaments and Neurofilament Proteins in Health and DiseasePreprint

Yuan, A., Rao, M. V., Veeranna, & Nixon, R. A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018309 · Cited by 741 · see citing works

Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738 · see citing works

Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies

Šimić, G., Leko, M. B., Wray, S., Harrington, C. R., Delalle, I., Milošević, N. J., Bažadona, D., Buée, L., de Silva, R., Giovanni, G. D., et al. (2016) · Biomolecules · doi:10.3390/biom6010006 · Cited by 698 · see citing works

Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects

Barbier, P., Zejneli, O., Martinho, M., Lasorsa, A., Belle, V., Smet‐Nocca, C., Tsvetkov, P. O., Devred, F., & Landrieu, I. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00204 · Cited by 623 · see citing works

Neurological and neuropsychiatric aspects of tuberous sclerosis complex

Curatolo, P., Moavero, R., & de Vries, P. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00069-1 · Cited by 600 · see citing works

Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2

Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L. (2005) · Nature Neuroscience · doi:10.1038/nn1566 · Cited by 497 · see citing works

The Synaptic Accumulation of Hyperphosphorylated Tau Oligomers in Alzheimer Disease Is Associated With Dysfunction of the Ubiquitin-Proteasome System

Tai, H., Serrano‐Pozo, A., Hashimoto, T., Frosch, M. P., Spires‐Jones, T. L., & Hyman, B. T. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.033 · Cited by 456 · see citing works

Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau

Alonso, A. D. C., Grundke-Iqbal, I., Barra, H. S., & Iqbal, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.298 · Cited by 437 · see citing works

Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction

Mietelska‐Porowska, A., Wasik, U., Goras, M., Filipek, A., & Niewiadomska, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034671 · Cited by 407 · see citing works

The tuberous sclerosis complex

Orlova, K. A., & Crino, P. B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05117.x · Cited by 405 · see citing works

Regulation of Actin Cytoskeleton Dynamics in Cells

Lee, S. H., & Domínguez, R. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0053-8 · Cited by 374 · see citing works

Axonal transport defects: a common theme in neurodegenerative diseases

Roy, S., Zhang, B., Lee, V. M. ‐., & Trojanowski, J. Q. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0952-x · Cited by 372 · see citing works

Microtubule-Associated Proteins: Structuring the Cytoskeleton

Bodakuntla, S., Jijumon, A. S., Villablanca, C., González-Billault, C. E., & Janke, C. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.07.004 · Cited by 366 · see citing works

<scp>mTOR</scp> regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies

Caccamo, A., Magrì, A., Medina, D. X., Wisely, E. V., López‐Aranda, M. F., Silva, A. J., & Oddo, S. (2013) · Aging Cell · doi:10.1111/acel.12057 · Cited by 362 · see citing works

Promotion of Hyperphosphorylation by Frontotemporal Dementia Tau Mutations

Alonso, A. D. C., Mederlyova, A., Novák, M., Grundke, I., & Iqbal, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405131200 · Cited by 330 · see citing works

mTOR signaling and its roles in normal and abnormal brain development

Takei, N., & Nawa, H. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00028 · Cited by 317 · see citing works

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288 · see citing works

Phosphorylation of tau protein at sites Ser 396–404 is one of the earliest events in A lzheimer's disease and D own syndrome

Mondragón‐Rodríguez, S., Perry, G. L., Luna‐Muñoz, J., Acevedo, M., & Williams, S. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12084 · Cited by 276 · see citing works

The MAP1 family of microtubule-associated proteins

Halpain, S., & Dehmelt, L. (2006) · Genome Biology · doi:10.1186/gb-2006-7-6-224 · Cited by 261 · see citing works

Tuberous sclerosis complex proteins control axon formationPreprint

Choi, Y.-J., Nardo, A. D., Kramvis, I., Meikle, L. M., Kwiatkowski, D. J., Şahin, M., & He, X. (2008) · Genes & Development · doi:10.1101/gad.1685008 · Cited by 258 · see citing works

Inhibition of microtubule assembly by phosphorylation of microtubule-associated proteins

Jameson, J. L., Frey, T., Zeebèrg, B. R., Dalldorf, F., & Caplow, M. (1980) · Biochemistry · doi:10.1021/bi00552a027 · Cited by 246 · see citing works

Tsc2-Rheb signaling regulates EphA-mediated axon guidance

Nie, D. A., Nardo, A. D., Han, J. M., Baharanyi, H., Kramvis, I., Huynh, T., Dabora, S. L., Codeluppi, S., Pandolfi, P. P., Pasquale, E. B., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2477 · Cited by 243 · see citing works

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Wu, M., Zhang, M., Yin, X., Chen, K., Hu, Z., Zhou, Q., Cao, X., Chen, Z., & Liu, D. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00270-1 · Cited by 241 · see citing works

Abnormal mTOR Activation in Autism

Winden, K. D., Ebrahimi‐Fakhari, D., & Şahin, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061747 · Cited by 222 · see citing works

Phenotypic spectrum of the tubulin-related disorders and functional implications of disease-causing mutations

Tischfield, M. A., Cederquist, G., Gupta, M. L., & Engle, E. C. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.01.003 · Cited by 222 · see citing works

Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex

Sato, A., Kasai, S., Kobayashi, T., Takamatsu, Y., Hino, O., Ikeda, K., & Mizuguchi, M. (2012) · Nature Communications · doi:10.1038/ncomms2295 · Cited by 219 · see citing works

Map1b Is Required for Axon Guidance and Is Involved in the Development of the Central and Peripheral Nervous System

Meixner, A., Haverkamp, S., Wässle, H., Pangratz-Fuehrer, S., Thalhammer, J. G., Kropf, N., Bittner, R. E., Lassmann, H., Wiche, G., & Propst, F. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1169 · Cited by 208 · see citing works

The Role of the Microtubule Cytoskeleton in Neurodevelopmental Disorders

Lasser, M., Tiber, J., & Lowery, L. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00165 · Cited by 201 · see citing works

Tau protein: Relevance to Parkinson's disease

Lei, P., Ayton, S., Finkelstein, D. I., Adlard, P. A., Masters, C. L., & Bush, A. I. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.07.016 · Cited by 193 · see citing works

Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction

Asano, E., Chugani, D. C., Muzik, O., Behen, M. E., Janisse, J. J., Rothermel, R. D., Mangner, T. J., Chakraborty, P. K., & Chugani, H. T. (2001) · Neurology · doi:10.1212/wnl.57.7.1269 · Cited by 178 · see citing works

Autism and the synapse

Ebrahimi‐Fakhari, D., & Şahin, M. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000186 · Cited by 166 · see citing works

Tau Phosphorylation at Serine 396 and Serine 404 by Human Recombinant Tau Protein Kinase II Inhibits Tau's Ability to Promote Microtubule Assembly

EVANS, D. B., Rank, K. B., Bhattacharya, K., Thomsen, D. R., Gurney, M. E., & Sharma, S. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000808200 · Cited by 155 · see citing works

Evidence for the Role of MAP1B in Axon Formation

González-Billault, C. E., Ávila, J., & Cáceres, A. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.7.2087 · Cited by 153 · see citing works

Neuronal abnormalities in microtubule-associated protein 1B mutant mice.

Edelmann, W., Zervas, M., Costello, P. S., Roback, L., Fischer, I., Hammarback, J. A., Cowan, N. J., Davies, P., Wainer, B. H., & Kucherlapati, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1270 · Cited by 149 · see citing works

mTOR-related synaptic pathology causes autism spectrum disorder-associated functional hyperconnectivity

Pagani, M., Barsotti, N., Bertero, A., Trakoshis, S., Ulysse, L., Locarno, A., Misevičiūtė, I., Felice, A. D., Canella, C., Supekar, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26131-z · Cited by 148 · see citing works

The emerging role of the tubulin code: From the tubulin molecule to neuronal function and disease

Chakraborti, S., Natarajan, K., Curiel, J., Janke, C., & Liu, J. S.-H. (2016) · Cytoskeleton · doi:10.1002/cm.21290 · Cited by 144 · see citing works

Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies

Muntané, G., Dalfó, E., Martı́nez, A., & Ferrer, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.030 · Cited by 143 · see citing works

Cerebral organoid and mouse models reveal a RAB39b–PI3K–mTOR pathway-dependent dysregulation of cortical development leading to macrocephaly/autism phenotypesPreprint

Zhang, W., Ma, L., Yang, M., Shao, Q., Xu, J., Lu, Z., Zhao, Z., Chen, R., Chai, Y., & Chen, J. (2020) · Genes & Development · doi:10.1101/gad.332494.119 · Cited by 142 · see citing works

Rapid Calpain I Activation and Cytoskeletal Protein Degradation Following Traumatic Spinal Cord Injury: Attenuation with Riluzole Pretreatment

Springer, J. E., Azbill, R. D., Kennedy, S. E., George, J., & Geddes, J. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041592.x · Cited by 141 · see citing works

Glycogen Synthase Kinase 3β Phosphorylates Alzheimer's Disease-Specific Ser³⁹⁶ of Microtubule-Associated Protein Tau by a Sequential Mechanism

Li, T., & Paudel, H. K. (2006) · Biochemistry · doi:10.1021/bi051634r · Cited by 140 · see citing works

Back to the tubule: microtubule dynamics in Parkinson’s disease

Pellegrini, L., Wetzel, A., Grannò, S., Heaton, G., & Harvey, K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2351-6 · Cited by 137 · see citing works

Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases

Sferra, A., Nicita, F., & Bertini, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197354 · Cited by 132 · see citing works

Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin

Hodges, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2899 · Cited by 126 · see citing works

Mammalian Target of Rapamycin (mTor) Mediates Tau Protein Dyshomeostasis

Tang, Z., Bereczki, E., Zhang, H., Wang, S., Li, C., Ji, X., Branca, R. M., Lehtiö, J., Guan, Z., Filipčík, P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435123 · Cited by 124 · see citing works

Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders

Muñoz-Lasso, D. C., Mateo, C. R., Pallardó, F. V., & González‐Cabo, P. (2020) · Cells · doi:10.3390/cells9020358 · Cited by 123 · see citing works

Microtubule and microtubule associated protein anomalies in psychiatric disease

Marchisella, F., Coffey, E. T., & Hollós, P. (2016) · Cytoskeleton · doi:10.1002/cm.21300 · Cited by 122 · see citing works

Synaptic tau: A pathological or physiological phenomenon?

Robbins, M., Clayton, E. L., & Schierle, G. S. K. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01246-y · Cited by 117 · see citing works

Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals

Mukaetova‐Ladinska, E. B., Arnold, H., Jaros, E., Perry, R., & Perry, E. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00574.x · Cited by 115 · see citing works

mTOR, a Potential Target to Treat Autism Spectrum Disorder

Sato, A. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160413120638 · Cited by 113 · see citing works

Symptom profiles of autism spectrum disorder in tuberous sclerosis complex

Jeste, S., Varcin, K. J., Hellemann, G., Gulsrud, A. C., Bhatt, R. R., Kasari, C. L., Wu, J. Y., Şahin, M., & Nelson, C. A. (2016) · Neurology · doi:10.1212/wnl.0000000000003002 · Cited by 113 · see citing works

mTor mediates tau localization and secretion: implication for Alzheimer’s disease

Tang, Z., Ioja, E., Bereczki, E., Hultenby, K., Li, C., Guan, Z., Winblad, B., & Pei, J.-J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.003 · Cited by 112 · see citing works

Tau and mTOR: The Hotspots for Multifarious Diseases in Alzheimer's Development

Mueed, Z., Tandon, P., Maurya, S. K., Deval, R., Kamal, M. A., & Poddar, N. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01017 · Cited by 111 · see citing works

mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders

Ryskalin, L., Limanaqi, F., Frati, A., Busceti, C. L., & Fornai, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082226 · Cited by 105 · see citing works

TSC1/TSC2 signaling in the CNS

Han, J. M., & Sahin, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.001 · Cited by 105 · see citing works

Autism and the Cerebellum: Evidence from Tuberous Sclerosis

Weber, A. M., Egelhoff, J. C., McKellop, J. M., & Franz, D. N. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005679108529 · Cited by 100 · see citing works

Tauopathy in the young autistic brain: novel biomarker and therapeutic target

Grigg, I., Ivashko‐Pachima, Y., Hait, T. A., Korenková, V., Touloumi, O., Lagoudaki, R., Dijck, A. V., Marušić, Z., Aničić, M., Vuković, J., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00904-4 · Cited by 100 · see citing works

Tau Reduction Prevents Key Features of Autism in Mouse Models

Tai, C., Chang, C.-W., Yu, G.-Q., Lopez, I., Yu, X., Wang, X., Guo, W., & Mucke, L. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.038 · Cited by 96 · see citing works

Pathologically phosphorylated tau at S396/404 (PHF-1) is accumulated inside of hippocampal synaptic mitochondria of aged Wild-type mice

Torres, A. K., Jara, C., Olesen, M. A., & Tapia‐Rojas, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-83910-w · Cited by 93 · see citing works

GSK3β-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling

Sánchez, C., Pérez, M., & Ávila, J. (2000) · European Journal of Cell Biology · doi:10.1078/s0171-9335(04)70028-x · Cited by 88 · see citing works

Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan

Mizuguchi, M., Ikeda, H., Kagitani‐Shimono, K., Yoshinaga, H., Suzuki, Y., Aoki, M., Endo, M., Yonemura, M., & Kubota, M. (2018) · Brain and Development · doi:10.1016/j.braindev.2018.07.003 · Cited by 85 · see citing works

Autism Spectrum Disorders in Tuberous Sclerosis: Pathogenetic Pathways and Implications for Treatment

Curatolo, P., Napolioni, V., & Moavero, R. (2010) · Journal of Child Neurology · doi:10.1177/0883073810361789 · Cited by 84 · see citing works

Protracted dendritic growth in the typically developing human amygdala and increased spine density in young ASD brains

Weir, R. K., Bauman, M. D., Jacobs, B., & Schumann, C. M. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24332 · Cited by 83 · see citing works

Novel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases

Heras-Sandoval, D., Pérez‐Rojas, J. M., & Pedraza‐Chaverrí, J. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109442 · Cited by 79 · see citing works

Autism and Epilepsy in Patients With Tuberous Sclerosis Complex

Specchio, N., Pietrafusa, N., Trivisano, M., Moavero, R., Palma, L. D., Ferretti, A., Vigevano, F., & Curatolo, P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00639 · Cited by 78 · see citing works

Cytosolic Abnormally Hyperphosphorylated Tau But Not Paired Helical Filaments Sequester Normal MAPs and Inhibit Microtubule Assembly

Iqbal, K., Alonso, A. D. C., & Grundke, I. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14402 · Cited by 77 · see citing works

Brain lesions in tuberous sclerosis complex. Review.

Grajkowska, W., Kotulska, K., Jurkiewicz, E., & Matyja, E. (2010) · PubMed · Cited by 77 · see citing works

Prenatal Exposure to Valproic Acid Affects Microglia and Synaptic Ultrastructure in a Brain-Region-Specific Manner in Young-Adult Male Rats: Relevance to Autism Spectrum Disorders

Gąssowska-Dobrowolska, M., Cieślik, M., Czapski, G. A., Jęśko, H. M., Frontczak‐Baniewicz, M., Gewartowska, M., Dominiak, A., Polowy, R., Filipkowski, R. K., Babiec, L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103576 · Cited by 75 · see citing works

The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC)

Feliciano, D. M. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.00039 · Cited by 69 · see citing works

Cytoskeletal regulation guides neuronal trafficking to effectively supply the synapse

Aiken, J., & Holzbaur, E. L. F. (2021) · Current Biology · doi:10.1016/j.cub.2021.02.024 · Cited by 61 · see citing works

The microtubule cytoskeleton at the synapse

Parato, J., & Bartolini, F. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135850 · Cited by 60 · see citing works

TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy

Alquezar, C., Schoch, K. M., Geier, E. G., Ramos, E. M., Scrivo, A., Li, K. H., Argouarch, A. R., Mlynarski, E. E., Dombroski, B., DeTure, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg3897 · Cited by 56 · see citing works

Autism and Intellectual Disability-Associated KIRREL3 Interacts with Neuronal Proteins MAP1B and MYO16 with Potential Roles in Neurodevelopment

Liu, Y. F., Sowell, S. M., Luo, Y. Y., Chaubey, A., Cameron, R. S., Kim, H.-G., & Srivastava, A. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123106 · Cited by 55 · see citing works

Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway

Mencer, S., Kartawy, M., Lendenfeld, F. V., Soluh, H., Tripathi, M. K., Халиулин, И. Г., & Amal, H. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01578-2 · Cited by 55 · see citing works

TOR signaling regulates microtubule structure and function

Choi, J. H., Adames, N. R., Chan, T., Zeng, C., Cooper, J. A., & Zheng, X.-F. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00599-6 · Cited by 54 · see citing works

Regulation of Microtubule-Dependent Protein Transport by the TSC2/Mammalian Target of Rapamycin Pathway

Jiang, X., & Yeung, R. S. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4510 · Cited by 50 · see citing works

Role of Microtubule-Associated Protein in Autism Spectrum Disorder

Chang, Q., Yang, H., Wang, M., Wei, H., & Hu, F. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0246-2 · Cited by 49 · see citing works

Alterations in Tau Protein Level and Phosphorylation State in the Brain of the Autistic-Like Rats Induced by Prenatal Exposure to Valproic Acid

Gąssowska-Dobrowolska, M., Kolasa, A., Cieślik, M., Dominiak, A., Friedland, K., & Adamczyk, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063209 · Cited by 45 · see citing works

Early autism symptoms in infants with tuberous sclerosis complex

McDonald, N. M., Varcin, K. J., Bhatt, R. R., Wu, J. Y., Şahin, M., Nelson, C. A., & Jeste, S. (2017) · Autism Research · doi:10.1002/aur.1846 · Cited by 44 · see citing works

Microtubule-associated protein 1B (MAP1B)-deficient neurons show structural presynaptic deficiencies in vitro and altered presynaptic physiology

Bodaleo, F. J., Montenegro‐Venegas, C., Henríquez, D. R., Court, F. A., & González-Billault, C. E. (2016) · Scientific Reports · doi:10.1038/srep30069 · Cited by 42 · see citing works

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis

Theunissen, F., West, P. K., Brennan, S. E., Petrović, B., Hooshmand, K., Akkari, P. A., Keon, M., & Guennewig, B. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00272-z · Cited by 42 · see citing works

Neurons: The Interplay between Cytoskeleton, Ion Channels/Transporters and Mitochondria

Alberti, P., Semperboni, S., Cavaletti, G., & Scuteri, A. (2022) · Cells · doi:10.3390/cells11162499 · Cited by 42 · see citing works

Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex

Yasuda, S., Sugiura, H., Katsurabayashi, S., Shimada, T., Tanaka, H., Takasaki, K., Iwasaki, K., Kobayashi, T., Hino, O., & Yamagata, K. (2014) · Scientific Reports · doi:10.1038/srep05155 · Cited by 42 · see citing works

MAP1B mutations cause intellectual disability and extensive white matter deficit

Walters, G. B., Gústafsson, Ó., Sveinbjörnsson, G., Eiriksdottir, V. K., Agustsdottir, A. B., Jónsdóttir, G. A., Steinberg, S., Gunnarsson, A. F., Magnusson, M. I., Unnsteinsdóttir, U., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05595-6 · Cited by 41 · see citing works

Genetic and clinical characteristics ofNEFL-related Charcot-Marie-Tooth disease

Horga, A., Laurá, M., Jaunmuktane, Z., Jerath, N. U., Gonzalez, M., Polke, J. M., Poh, R., Blake, J. C., Liu, Y., Wiethoff, S., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-315077 · Cited by 41 · see citing works

Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders

Bonini, S. A., Mastinu, A., Ferrari‐Toninelli, G., & Memo, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081627 · Cited by 40 · see citing works

Neuroimaging in tuberous sclerosis complex

Russo, C., Nastro, A., Cicala, D., Liso, M. D., Covelli, E. M., & Cinalli, G. (2020) · Child s Nervous System · doi:10.1007/s00381-020-04705-4 · Cited by 40 · see citing works

RHOA signaling defects result in impaired axon guidance in iPSC-derived neurons from patients with tuberous sclerosis complex

Catlett, T. S., Onesto, M. M., McCann, A. J., Rempel, S. K., Glass, J., Franz, D. N., & Gómez, T. M. (2021) · Nature Communications · doi:10.1038/s41467-021-22770-4 · Cited by 39 · see citing works

Neuronal Cytoskeleton in Intellectual Disability: From Systems Biology and Modeling to Therapeutic Opportunities

Liaci, C., Camera, M., Caslini, G., Rando, S., Contino, S., Romano, V., & Merlo, G. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116167 · Cited by 39 · see citing works

Tubulin mutations in neurodevelopmental disorders as a tool to decipher microtubule function

Fourel, G., & Boscheron, C. (2020) · FEBS Letters · doi:10.1002/1873-3468.13958 · Cited by 38 · see citing works

Effects of Mutations in TSC Genes on Neurodevelopment and Synaptic Transmission

Bassetti, D., Luhmann, H. J., & Kirischuk, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147273 · Cited by 38 · see citing works

Dysfunction of microtubule-associated proteins of MAP2/tau family in Prion disease

Zhang, J., & Dong, X. (2012) · Prion · doi:10.4161/pri.20677 · Cited by 37 · see citing works

The Cytoskeletal Elements MAP2 and NF-L Show Substantial Alterations in Different Stroke Models While Elevated Serum Levels Highlight Especially MAP2 as a Sensitive Biomarker in Stroke Patients

Mages, B., Fuhs, T., Aleithe, S., Blietz, A., Hobusch, C., Härtig, W., Schob, S., Krueger, M., & Michalski, D. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02372-3 · Cited by 36 · see citing works

A molecular cascade modulates MAP1B and confers resistance to mTOR inhibition in human glioblastoma

Laks, D. R., Osés-Prieto, J. A., Alvarado, A. G., Nakashima, J. K., Chand, S., Azzam, D., Gholkar, A. A., Sperry, J., Ludwig, K., Condro, M. C., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox215 · Cited by 33 · see citing works

mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus

Petrásek, T., Vojtěchová, I., Klovrza, O., Tuckova, K., Vejmola, Č., Rak, J., Šuláková, A., Kaping, D., Bernhardt, N. R., de Vries, P. J., et al. (2021) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09357-2 · Cited by 32 · see citing works

Complex Neurological Phenotype in Mutant Mice LackingTsc2in Excitatory Neurons of the Developing Forebrain

Crowell, B., Lee, G. H., Nikolaeva, I., Pozzo, V. D., & D’Arcangelo, G. (2015) · eNeuro · doi:10.1523/eneuro.0046-15.2015 · Cited by 30 · see citing works

Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in Alzheimer's disease, cerebral ischemia and multiple sclerosis (Review)

Vargas, J. A. G., Castro-Álvarez, J. F., Berruecos, J. F. Z., Abdul‐Rahim, K., & Arteaga‐Noriega, A. (2022) · Biomedical Reports · doi:10.3892/br.2022.1510 · Cited by 30 · see citing works

Dysfunctional proteins in neuropsychiatric disorders: From neurodegeneration to autism spectrum disorders

Jęśko, H. M., Cieślik, M., Gromadzka, G., & Adamczyk, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104853 · Cited by 29 · see citing works

Alterations in neuronal cytoskeletal and astrocytic proteins content in the brain of the autistic-like mouse strain C58/J

Barón-Mendoza, I., Garcı́a, O., Calvo‐Ochoa, E., Rebollar-García, J. O., Garzón-Cortés, D., Haro, R., & González‐Arenas, A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.004 · Cited by 27 · see citing works

Tuberous Sclerosis Complex

Paturel, A. (2011) · Neurology Now · doi:10.1097/01.nnn.0000399235.15726.3e · Cited by 25 · see citing works

MAP1B Light Chain Modulates Synaptic Transmission via AMPA Receptor Intracellular Trapping

Palenzuela, R., Gutiérrez, Y., Draffin, J. E., Lario, A., Benoist, M., & Esteban, J. A. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0505-17.2017 · Cited by 22 · see citing works

Reduced plasma levels of microtubule-associated STOP/MAP6 protein in autistic patients

Wei, H., Sun, S.-B., Li, Y., & Yu, S. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.08.024 · Cited by 20 · see citing works

Neurofilament Light (NF-L) Chain Protein from a Highly Polymerized Structural Component of the Neuronal Cytoskeleton to a Neurodegenerative Disease Biomarker in the Periphery

Lukiw, W. J. (2021) · Alzheimer’s & Neurodegenerative Diseases · doi:10.24966/and-9608/100056 · Cited by 20 · see citing works

The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP

Gozes, I. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0152 · Cited by 19 · see citing works

Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia

Liu, A. J., Staffaroni, A. M., Rojas-Martinez, J. C., Olney, N. T., Alquezar-Burillo, C., Ljubenkov, P. A., La Joie, R., Fong, J. C., Taylor, J., Karydas, A., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4284 · Cited by 18 · see citing works

The microtubule skeleton and the evolution of neuronal complexity in vertebrates

Trushina, N., Mulkidjanian, A., & Brandt, R. (2019) · Biological chemistry · doi:10.1515/hsz-2019-0149 · Cited by 18 · see citing works

Tau: A Novel Entry Point for mTOR-Based Treatments in Autism Spectrum Disorder?

Modi, M. E., & Şahin, M. (2020) · Neuron · doi:10.1016/j.neuron.2020.04.019 · Cited by 17 · see citing works

Depotentiation of Long-Term Potentiation Is Associated with Epitope-Specific Tau Hyper-/Hypophosphorylation in the Hippocampus of Adult Rats

Babür, E., Tan, B., Delibaş, S., Yousef, M., Dursun, N., & Süer, C. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1224-x · Cited by 16 · see citing works

Tuberous sclerosis complex is a novel, amyloid-independent tauopathy associated with elevated phosphorylated 3R/4R tau aggregation

Liu, A. J., Lusk, J. B., Ervin, J., Burke, J., O’Brien, R., & Wang, S.-H. J. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01330-x · Cited by 15 · see citing works

Synaptic Alterations in a Transgenic Model of Tuberous Sclerosis Complex: Relevance to Autism Spectrum Disorders

Czapski, G. A., Babiec, L., Jęśko, H. M., Gąssowska-Dobrowolska, M., Cieślik, M., Matuszewska, M., Frontczak‐Baniewicz, M., Zajdel, K., & Adamczyk, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810058 · Cited by 15 · see citing works

Elevated serum neurofilament light chain in children autism spectrum disorder: A case control study

He, W., Zhang, X.-J., Zhang, Y.-Q., & Zhang, W. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.06.012 · Cited by 14 · see citing works

Alterations in Cerebellar Microtubule Cytoskeletal Network in a ValproicAcid-Induced Rat Model of Autism Spectrum Disorders

Gąssowska-Dobrowolska, M., Kolasa, A., Beversdorf, D. Q., & Adamczyk, A. (2022) · Biomedicines · doi:10.3390/biomedicines10123031 · Cited by 13 · see citing works

Microtubule dynamics in cytoskeleton, neurodegenerative and psychiatric disease

Mortal, S. (2021) · STEMedicine · doi:10.37175/stemedicine.v2i6.81 · Cited by 10 · see citing works

Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling

Ferrer, I., Mohan, P., Chen, H., Castellsagué, J., Gómez‐Baldó, L., Carmona, M., García, N., Aguilar, H., Jiang, J., Skowron, M. A., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4343 · Cited by 9 · see citing works

Editorial: Shaping the Brain by Neuronal Cytoskeleton: From Development to Disease and Degeneration

Ávila, J., Sousa, M. M., & Sayas, C. L. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00012 · Cited by 9 · see citing works

Mislocalization of TORC1 to Lysosomes Caused by KIF11 Inhibition Leads to Aberrant TORC1 Activity.

Jang, Y., Choi, Y., Jun, K., & Chung, J. (2020) · PubMed Central · doi:10.14348/molcells.2020.0089 · Cited by 7 · see citing works

Neurocytoskeletal Changes Following Traumatic Brain Injury

Huh, J. W., Helfaer, M. A., McIntosh, T. K., & Saatman, K. E. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1721-4_12 · Cited by 4 · see citing works

Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer’s Disease: A Recent Systematic Review

Munteanu, C., Iordan, D. A., Hoteteu, M., Popescu, C., POSTOIU, R. L., Onu, I., & Onose, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015481 · Cited by 23 · see citing works

Is tuberous sclerosis complex-associated autism a preventable and treatable disorder?

Curatolo, P., Scheper, M., Gialloreti, L. E., Specchio, N., & Aronica, E. (2023) · World Journal of Pediatrics · doi:10.1007/s12519-023-00762-2 · Cited by 17 · see citing works

mTOR signaling pathway as a pathophysiologic mechanism in preclinical models of autism spectrum disorder

Drehmer, I., Santos‐Terra, J., Gottfried, C., & Deckmann, I. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.10.050 · Cited by 17 · see citing works

Neuroplasticity mechanisms of NDBIs in autism: a review from brain connectivity to behavioral improvement

Yan, P., Zhu, X., Tao, Q., & 邵宪花 (2026) · European journal of medical research · doi:10.1186/s40001-026-03873-4 · Cited by 4 · see citing works

Architects of the Developing Brain: Cytoskeleton-Organizing Molecules in Neurodevelopmental Disorders

Achkasova, K. A., Subbotin, P. V., Zhukov, V., Filat’eva, A. E., Tarabykin, V. S., & Kondakova, E. V. (2026) · Cells · doi:10.3390/cells15060537 · Cited by 3 · see citing works

Disentangling the role of tau pathology in autism spectrum disorders

Villavicencio-Tejo, F., Olesen, M. A., Moya, M. L., & Quintanilla, R. A. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111496 · Cited by 4 · see citing works

Tau Hypophosphorylation at Ser416 as the Early Molecular Imprint of Maternal Immune Activation: Insights from Female Mice Offspring

Bielska, E., Matuszewska, M., Wójcik, P., Wilkaniec, A., Cieślik, M., Gąssowska-Dobrowolska, M., Sulejczak, D., Czapski, G. A., & Adamczyk, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110778 · Cited by 2 · see citing works

Amyloid-Independent Elevation of Plasma phosphorylated tau-217 Tracks Neurodegenerative Risk in Tuberous Sclerosis Complex: Implications for mTOR-Targeted Intervention

Baumel, J., Lutz, M., Ding, C., Capal, J., Ritter, D., Krueger, D., Salter, A., Werner, K., & Liu, A. J. (2026) · medRxiv · doi:10.64898/2026.09.09.26362677

ENT1 inhibitor J4 restores cognitive function and white-matter integrity in a mouse model of tuberous sclerosis complex

Hsieh, C. C., Tsou, Y., Huang, N., Chen, T., Li, S., Chang, C.-W., Lin, W.-X., Tung, S.-Y., Chern, Y., Chen, Y. L., et al. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01269-4 · Cited by 1 · see citing works

Association of MAP2 gene polymorphisms and altered expression with schizophrenia risk in a Chinese Han population

Yang, M. H., Yu, J., Chang, Y., Chen, Y., Xie, W., Liu, L., 霍正浩, Zx, M., & Dang, J. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1844302

Elastomeric 3D‐Printed Microenvironments Enable Nanonewton Force Measurements in Healthy and Diseased Human Pluripotent Stem Cell‐Derived Neuroepithelial Cells

van Altena, P. F. J., Ransanz, L. C., Guis, R. H., Bergamaschi, G., Paauw, N. J., Staufer, U., Heine, V. M., & Accardo, A. (2026) · Advanced Materials · doi:10.1002/adma.74596

Synaptic Alterations in a Transgenic Model of Tuberous Sclerosis Complex: Relevance to Autism Spectrum Disorders

Czapski, G. A., Babiec, L., Jęśko, H. M., Gąssowska-Dobrowolska, M., Cieślik, M., Matuszewska, M., Frontczak‐Baniewicz, M., Zajdel, K., & Adamczyk, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810058 · Cited by 15 · see citing works

CHARACTERIZATION AND TREATMENT OF A NOVEL MOUSE MODEL OF TSC-ASSOCIATED AUTISM

Reith, R. M. (2012) · Digital Commons-TMC (Texas Medical Center)

Autism Spectrum Disorders in Tuberous Sclerosis

Jülich, K., & Şahin, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_184 · Cited by 5 · see citing works

Disentangling the role of tau pathology in autism spectrum disorders

Villavicencio-Tejo, F., Olesen, M. A., Moya, M. L., & Quintanilla, R. A. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111496 · Cited by 4 · see citing works

Alterations in neuronal cytoskeletal and astrocytic proteins content in the brain of the autistic-like mouse strain C58/J

Barón-Mendoza, I., Garcı́a, O., Calvo‐Ochoa, E., Rebollar-García, J. O., Garzón-Cortés, D., Haro, R., & González‐Arenas, A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.004 · Cited by 27 · see citing works